Table S4: Physiological differences in CA1 pyramidal cells.
Dorsal (n=46)
Ventral (n=31)
p value
(mean +/- SEM)
(mean +/- SEM)
Rn (MOhm)
107 +/- 3
179 +/- 15
<1e-6
RMP (mV)
-66.6 +/- 0.3
-68.6 +/- 0.5
<0.001
AHP amplitude (mV)
-0.776 +/- 0.024
-0.931 +/- 0.04
<0.01
First spike amplitude (mV)
98.1 +/- 0.5
95.8 +/- 0.7
<0.01
Sag ratio
0.709 +/- 0.004
0.734 +/- 0.008
<0.01
First spike threshold (mV)
-52.4 +/- 0.4
-50.2 +/- 8
<0.01
Second spike threshold (mV)
-38.8 +/- 0.5
-36.6 +/- 0.9
<0.05
First spike maximum falling dV/dt (mV/ms)
-112 +/- 1
-116 +/- 1
<0.05
Second spike maximum falling dV/dt (mV/ms)
-70.8 +/- 1.5
-75.9 +/- 2.2
n.s.
ADP amplitude (mV)
28.3 +/- 0.4
29.6 +/- 0.7
n.s.
Second spike amplitude (mV)
73.7 +/- 1.3
69.9 +/- 2.0
n.s.
Second spike FWHM (ms)
1.34 +/- 0.02
1.28 +/- 0.03
n.s.
Subthreshold dV/dt (mV/ms)
22.5 +/- 1.1
21.6 +/- 1.6
n.s.
Spike 1 FWHM (ms)
0.901 +/- 0.001
0.895 +/- 0.017
n.s.
First spike maximum rising dV/dt (mV/ms)
662 +/- 12
656 +/- 17
n.s.
Second spike maximum rising dV/dt (mV/ms)
263 +/- 11
258 +/- 17
n.s.
Related to Fig. 3. Summary of the electrophysiological parameters profiled for dorsal and ventral CA1 pyramidal cells. Table combines positive and negative Vipr2-RFP cells:
